Apolipoproteins and aging: Emerging mechanisms

Ageing Research Reviews

Volumn 1, Issue 3, 2002, Pages 345-365

  Smith, Jonathan D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cardiovascular disease; Longevity

Indexed keywords

4 HYDROXYNONENAL; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LAMININ; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; TAU PROTEIN; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN SIZE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; GENDER; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEAD INJURY; HEART DISEASE; HEREDITY; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LONGEVITY; MEMORY DISORDER; MORTALITY; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SENILE PLAQUE; SMELLING; STROKE; SURVIVAL; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS; APOLIPOPROTEINS E; COGNITION DISORDERS; HUMANS; VARIATION (GENETICS);

EID: 0036598957     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(02)00005-3     Document Type: Review

References (173)

1. Alafuzoff I., Helisalmi S., Mannermaa A., Soininen H. Severity of cardiovascular disease, apolipoprotein E genotype and brain pathology in aging and dementia. Ann. N.Y. Acad. Sci. 903:2000;244-251.
2. Bader G., Zuliani G., Kostner G.M., Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology. 44:1998;293-299.
3. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:1997;263-264.
4. Bales K.R., Verina T., Cummins D.J., Du Y., Dodel R.C., Saura J., Fishman C.E., DeLong C.A., Piccardo P., Petegnief V., Ghetti B., Paul S.M. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 96:1999;15233-15238.
5. Barger S.W., Mattson M.P. Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J. Neurochem. 69:1997;60-67.
6. Bartres-Faz D., Junque C., Lopez A., Valveny N., Moral P., Galvez E., Lopez T., Moya A., Navarro J.L., Clemente I. The apoE influences declarative and procedural learning in age-associated memory impairment. Neuroreport. 10:1999;2923-2927.
7. Beffert U., Aumont N., Dea D., Lussier-Cacan S., Davignon J., Poirier J. β-Amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J. Neurochem. 70:1998;1458-1466.
8. Berr C., Dufouil C., Brousseau T., Richard F., Amouyel P., Marceteau E., Alperovitch A. Early effect of apoE-ε4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Arteriel. Neurosci. Lett. 218:1996;9-12.
9. Bi X., Yong A.P., Zhou J., Ribak C.E., Lynch G. Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8832-8837.
10. Biere A.L., Ostaszewski B., Zhao H., Gillespie S., Younkin S.G., Selkoe D.J. Co-expression of β-amyloid precursor protein (β-APP) and apolipoprotein E in cell culture: analysis of β-APP processing. Neurobiol. Dis. 2:1995;177-187.
11. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C.P., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. The apoE4 and age at onset of Alzheimer's disease - the NIMH genetics initiative. Neurology. 48:1997;139-147.
12. Blanche H., Cabanne L., Sahbatou M., Thomas G. A study of French centenarians: are ACE and apoE associated with longevity? C.R. Acad. Sci. III. 324:2001;129-135.
13. Borchelt D.R., Ratovitski T., van L.J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
14. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with non-myelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513.
15. Bretsky P.M., Buckwalter J.G., Seeman T.E., Miller C.A., Poirier J., Schellenberg G.D., Finch C.E., Henderson V.W. Evidence for an interaction between apolipoprotein E genotype, gender and Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 13:1999;216-221.
16. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of apoE associated with risk for Alzheimer's dementia: in process citation. Nat. Genet. 18:1998;69-71.
17. Carter D.B., Dunn E., McKinley D.D., Stratman N.C., Boyle T.P., Kuiper S.L., Oostveen J.A., Weaver R.J., Boller J.A., Gurney M.E. Human apolipoprotein E4 accelerates β-amyloid deposition in APPsw transgenic mouse brain. Ann. Neurol. 50:2001;468-475.
18. Caselli R.J., Osborne D., Reiman E.M., Hentz J.G., Barbieri C.J., Saunders A.M., Hardy J., Hall G.R., Alexander G.E. Pre-clinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-ε4/4 homozygotes: a replication study. J. Neurol. Sci. 189:2001;93-98.
19. Cataldo A.M., Peterhoff C.M., Troncoso J.C., Gomez-Isla T., Hyman B.T., Nixon R.A. Endocytic pathway abnormalities precede amyloid β-deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of apoE genotype and presenilin mutations. Am. J. Pathol. 157:2000;277-286.
20. Cauley J.A., Eichner J.E., Kamboh M.I., Ferrell R.E., Kuller L.H. The apoE allele frequencies in younger (age 42-50) versus older (age 65-90) women. Genet. Epidemiol. 10:1993;27-34.
21. Cauley J.A., Zmuda J.M., Yaffe K., Kuller L.H., Ferrell R.E., Wisniewski S.R., Cummings S.R. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - the study of osteoporotic fractures. J. Bone Miner. Res. 14:1999;1175-1181.
22. Celsis P. Age-related cognitive decline, mild cognitive impairment or pre-clinical Alzheimer's disease? Ann. Med. 32:2000;6-14.
23. Cohen R.M., Small C., Lalonde F., Friz J., Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology. 57:2001;2223-2228.
24. Cole G.M., Beech W., Frautschy S.A., Sigel J., Glasgow C., Ard M.D. Lipoprotein effects on a β-accumulation and degradation by microglia in vitro. J. Neurosci. Res. 57:1999;504-520.
25. Collie A., Maruff P., Shafiq-Antonacci R., Smith M., Hallup M., Schofield P.R., Masters C.L., Currie J. Memory decline in healthy older people: implications for identifying mild cognitive impairment. Neurology. 56:2001;1533-1538.
26. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
27. Corder E.H., Lannfelt L., Viitanen M., Corder L.S., Manton K.G., Winblad B., Basun H. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch. Neurol. 53:1996;418-422.
28. Craft S., Teri L., Edland S.D., Kukull W.A., Schellenberg G., McCormick W.C., Bowen J.D., Larson E.B. Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease. Neurology. 51:1998;149-153.
29. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
30. 18F]fluoro-2-deoxy-D-glucose/poitron emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U.S.A. 98:2001;10966-10971.
31. DeCarli C., Miller B.L., Swan G.E., Reed T., Wolf P.A., Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung and Blood Institute twin study. Arch. Neurol. 58:2001;643-647.
32. DeKroon R.M., Armati P.J. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol. Dis. 8:2001;78-89.
33. Dik M.G., Deeg D.J., Bouter L.M., Corder E.H., Kok A., Jonker C. Stroke and apolipoprotein E-ε4 are independent risk factors for cognitive decline: a population-based study. Stroke. 31:2000;2431-2436.
34. Dik M.G., Jonker C., Comijs H.C., Bouter L.M., Twisk J.W., van Kamp G.J., Deeg D.J. Memory complaints and apoE-ε4 accelerate cognitive decline in cognitively normal elderly. Neurology. 57:2001;2217-2222.
35. Dong L.M., Wilson C., Wardell M.R., Simmons T., Mahley R.W., Weisgraber K.H., Agard D.A. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269:1994;22358-22365.
36. Drigalenko E., Poduslo S., Elston R. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology. 51:1998;131-135.
37. Du Y.S., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schmidt A.M. β-Amyloid peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a pro-inflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5296-5301.
38. Egensperger R., Kosel S., von Eitzen U., Graeber M.B. Microglial activation in Alzheimer disease: association with apoE genotype. Brain Pathol. 8:1998;439-447.
39. Ehnholm C., Lukka M., Kuusi T., Nikkila E., Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid Res. 27:1986;227-235.
40. Evans A.E., Zhang W., Moreel J.F., Bard J.M., Ricard S., Poirier O., Tiret L., Fruchart J.C., Cambien F. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum. Genet. 92:1993;191-197.
41. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van D.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease, A meta-analysis. JAMA. 278:1997;1349-1356.
42. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Abetas 42 and 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5856-5861.
43. Fillenbaum G.G., Landerman L.R., Blazer D.G., Saunders A.M., Harris T.B., Launer L.J. The relationship of apoE genotype to cognitive functioning in older African-American and Caucasian community residents. J. Am. Geriatr. Soc. 49:2001;1148-1155.
44. Fleming L.M., Weisgraber K.H., Strittmatter W.J., Troncoso J.C., Johnson G.V. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp. Neurol. 138:1996;252-260.
45. Frisoni G.B., Louhija J., Geroldi C., Trabucchi M. Longevity and the ε2 allele of apolipoprotein E: the Finnish centenarians study. J. Gerontol. A Biol. Sci. Med. Sci. 56:2001;M75-M78.
46. Galinsky D., Tysoe C., Brayne C.E., Easton D.F., Huppert F.A., Dening T.R., Paykel E.S., Rubinsztein D.C. Analysis of the apoE/apoC-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 129:1997;177-183.
47. Gerdes L.U., Jeune B., Ranberg K.A., Nybo H., Vaupel J.W. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a frailty gene, not a longevity gene. Genet. Epidemiol. 19:2000;202-210.
48. Gomez-Isla T., West H.L., Rebeck G.W., Harr S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitz L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein E-ε4 in Alzheimer's disease. Ann. Neurol. 39:1996;62-70.
49. Greenwood P.M., Sunderland T., Friz J.L., Parasuraman R. Genetics and visual attention: selective deficits in healthy adult carriers of the ε4 allele of the apolipoprotein E gene. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11661-11666.
50. Growdon, J.H., Locascio, J.J., Corkin, S., Gomez-Isla, T., Hyman, B.T., 1996. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 47, 444-448 [See comments].
51. Guo Z., Cupples L.A., Kurz A., Auerbach S.H., Volicer L., Chui H., Green R.C., Sadovnick A.D., Duara R., DeCarli C., Johnson K., Go R.C., Growdon J.H., Haines J.L., Kukull W.A., Farrer L.A. Head injury and the risk of AD in the MIRAGE study. Neurology. 54:2000;1316-1323.
52. Gylling H., Miettinen T.A. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J. Lipid Res. 33:1992;1361-1371.
53. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of apoE-ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 282:1999;40-46.
54. Hallman D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Csazar A., Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:1991;338-349.
55. Hartman R.E., Wozniak D.F., Nardi A., Olney J.W., Sartorius L., Holtzman D.M. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 170:2001;326-344.
56. Hashimoto Y., Jiang H., Niikura T., Ito Y., Hagiwara A., Umezawa K., Abe Y., Murayama Y., Nishimoto I. Neuronal apoptosis by apolipoprotein E4 through low density lipoprotein receptor-related protein and heterotrimeric GTPases. J. Neurosci. 20:2000;8401-8409.
57. Helkala E.L., Koivisto K., Hanninen T., Vanhanen M., Kervinen K., Kuusisto J., Mykkanen L., Kesaniemi Y.A., Laakso M., Riekkinen P.S. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci. Lett. 204:1996;177-180.
58. Herskind A.M., McGue M., Holm N.V., Sorensen T.I., Harvald B., Vaupel J.W. The heritability of human longevity: a population-based study of 2872 Danish twin pairsborn 1870-1900. Hum. Genet. 97:1996;319-323.
59. Hirose N., Homma S., Arai Y., Kawamura M., Hasegawa H., Ishida H., Shimizu K., Osono Y., Homma A., Nakamura Y. Tokyo centenarian study. Part 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo metropolitan area. Nippon Ronen Igakkai Zasshi. 34:1997;267-272.
60. Hixson J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arterioscler. Thromb. 11:1991;1237-1244.
61. Hogh P., Knudsen G.M., Kjaer K.H., Jorgensen O.S., Paulson O.B., Waldemar G. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the ε4 allele on regional cerebral blood flow. J. Geriatr. Psychiatry Neurol. 14:2001;42-51.
62. Holmes C., Levy R., McLoughlin D.M., Powell J.F., Lovestone S. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 61:1996;580-583.
63. Holtzman D.M., Bales K.R., Wu S., Bhat P., Parsadanian M., Fagan A.M., Chang L.K., Sun Y., Paul S.M. Expression of human apolipoprotein E reduces β-amyloid deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103:1999;15-21.
64. Holtzman D.M., Fagan A.M., Mackey B., Tenkova T., Sartorius L., Paul S.M., Bales K., Ashe K.H., Irizarry M.C., Hyman B.T. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47:2000a;739-747.
65. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2892-2897.
66. Horsburgh K., McCarron M.O., White F., Nicoll J.A. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol. Aging. 21:2000;245-255.
67. Howard B.V., Gidding S.S., Liu K. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA study coronary artery risk development in young adults. Am. J. Epidemiol. 148:1998;859-868.
68. Hu J., LaDu M.J., Van Eldik L.J. Apolipoprotein E attenuates β-amyloid-induced astrocyte activation. J. Neurochem. 71:1998;1626-1634.
69. Huang D.Y., Weisgraber K.H., Strittmatter W.J., Matthew W.D. Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp. Neurol. 136:1995;251-257.
70. Huang Y., Liu X.Q., Wyss-Coray T., Brecht W.J., Sanan D.A., Mahley R.W. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8838-8843.
71. Hyman B.T., West H.L., Rebeck G.W., Buldyrev S.V., Mantegna R.N., Ukleja M., Havlin S., Stanley H.E. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. U.S.A. 92:1995;3586-3590.
72. Hyman B.T., Strickland D., Rebeck G.W. Role of the low density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer's disease. Arch. Neurol. 57:2000;646-650.
73. Ilveskoski E., Perola M., Lehtimaki T., Laippala P., Savolainen V., Pajarinen J., Penttila A., Lalu K.H., Mannikko A., Liesto K.K., Koivula T., Karhunen P.J. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation. 100:1999;608-613.
74. Ilveskoski E., Loimaala A., Mercuri M.F., Lehtimaki T., Pasanen M., Nenonen A., Oja P., Bond M.G., Koivula T., Karhunen P.J., Vuori I. Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men. Atherosclerosis. 153:2000;147-153.
75. Irizarry M.C., Cheung B.S., Rebeck G.W., Paul S.M., Bales K.R., Hyman B.T. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP(V717F) transgenic mice. Acta Neuropathol. (Berlin). 100:2000;451-458.
76. Jian-Gang Z., Yong-Xing M., Chuan-Fu W., Pei-Fang L., Song-Bai Z., Nui-Fan G., Guo-Yin F., Lin H. Apolipoprotein E and longevity among Han Chinese population. Mech. Ageing Dev. 104:1998;159-167.
77. Jordan B.D., Relkin N.R., Ravdin L.D., Jacobs A.R., Bennett A., Gandy S. Apolipoprotein E-ε4 associated with chronic traumatic brain injury in boxing. JAMA. 278:1997;136-140.
78. Kehoe P., Wavrant-De V.F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van V.W., Ramic D., Williams J., Goate A., Hardy J., Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8:1999;237-245.
79. Kervinen K., Savolainen M.J., Salokannel J., Hynninen A., Heikkinen J., Ehnholm C., Koistinen M.J., Kesaniemi Y.A. Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis. 105:1994;89-95.
80. Kesaniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J. Clin. Invest. 80:1987;578-581.
81. Kraft H.G., Menzel H.J., Hoppichler F., Vogel W., Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation: implications for apolipoprotein synthesis. J. Clin. Invest. 83:1989;137-142.
82. Kuusisto J., Mykkanen L., Kervinen K., Kesaniemi Y.A., Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler. Thromb. Vasc. Biol. 15:1995;1280-1286.
83. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apoE to β-amyloid. J. Biol. Chem. 269:1994;23403-23406.
84. LaDu M.J., Pederson T.M., Frail D.E., Reardon C.M., Getz S.G., Falduto M.T. Purification of apoE attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270:1995;9039-9042.
85. Lahoz C., Schaefer E.J., Cupples L.A., Wilson P.W., Levy D., Osgood D., Parpos S., Pedro-Botet J., Daly J.A., Ordovas J.M. Apolipoprotein E genotype and cardiovascular disease in the Framingham heart study. Atherosclerosis. 154:2001;529-537.
86. Lambert J.C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Perez-tur J., Mouroux V., Mohr M., Cecyre D., Galasko D., Lendon C., Poirier J., Hardy J., Mann D., Amouyel P., Chartier-Harlin M.C. Pronounced impact of Th1/E47cs mutation compared with 491 AT mutation on neural apoE gene expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;1511-1516.
87. Lautenschlager N.T., Cupples L.A., Rao V.S., Auerbach S.A., Becker R., Burke J., Chui H., Duara R., Foley E.J., Glatt S.L., Green R.C., Jones R., Karlinsky H., Kukull W.A., Kurz A., Larson E.B., Martelli K., Sadovnick A.D., Volicer L., Waring S.C., Growdon J.H., Farrer L.A. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology. 46:1996;641-650.
88. Lee J.H., Tang M.X., Schupf N., Stern Y., Jacobs D.M., Tycko B., Mayeux R. Mortality and apolipoprotein E in Hispanic, African-American and Caucasian elders, African-American and Caucasian elders? Am. J. Med. Genet. 103:2001;121-127.
89. Lehtovirta M., Laakso M.P., Frisoni G.B., Soininen H. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol. Aging. 21:2000;293-300.
90. Lesuisse C., Xu G., Anderson J., Wong M., Jankowsky J., Holtz G., Gonzalez V., Wong P.C., Price D.L., Tang F., Wagner S., Borchelt D.R. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum. Mol. Genet. 10:2001;2525-2537.
91. Linton M.F., Gish R., Hubl S.T., Butler E., Esquivel C., Bry W.I., Boyles J.K., Wardell M.R., Young S.G. Phenotypes of apolipoproteins B and E after liver transplantation. J. Clin. Invest. 88:1991;270-281.
92. Louhija, J., Mieettinin, H.E., Kontula, K., Tikkanen, M.J., Miettinen, T.A., Tilvis, R.S., 1994. Aging and genetic variation of plasma apolipoproteins. Arterioscler. Thromb. 14, 1084-1089.
93. Ma J., Yee A., Brewer H.B., Das S., Potter H. Amyloid-associated proteins a1-antichymotrypsin and apoE promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
94. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
95. Mahley R.W., Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10:1999;207-217.
96. Mayeux R., Small S.A., Tang M., Tycko B., Stern Y. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein E. Neurobiol. Aging. 22:2001;683-689.
97. McCarron M.O., Delong D., Alberts M.J. The apoE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis in process citation. Neurology. 53:1999;1308-1311.
98. Mehta K.M., Ott A., Kalmijn S., Slooter A.J., van Duijn C.M., Hofman A., Breteler M.M. Head trauma and risk of dementia and Alzheimer's disease: the Rotterdam study. Neurology. 53:1999;1959-1962.
99. Menzel H.J., Kladetzky R.G., Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 3:1983;310-315.
100. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and specific effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Genet. 14:1996;55-61.
101. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology. 55:2000;134-136.
102. Moir R.D., Atwood C.S., Romano D.M., Laurans M.H., Huang X., Bush A.I., Smith J.D., Tanzi R.E. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of Abeta using physiological concentrations. Biochemistry. 38:1999;4595-4603.
103. Montine T.J., Montine K.S., Olson S.J., Graham D.G., Roberts L.J., Morrow J.D., Linton M.F., Fazio S., Swift L.L. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Exp. Neurol. 158:1999;234-241.
104. Mortensen E.L., Hogh P. A gender difference in the association between apoE genotype and age-related cognitive decline. Neurology. 57:2001;89-95.
105. Mulder M., Blokland A., van den Berg D.J., Schulten H., Bakker A.H., Terwel D., Honig W., de Kloet E.R., Havekes L.M., Steinbusch H.W., de Lange E.C. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab. Invest. 81:2001;953-960.
106. Murphy C., Bacon A.W., Bondi M.W., Salmon D.P. Apolipoprotein E status is associated with odor identification deficits in non-demented older persons. Ann. N.Y. Acad. Sci. 855:1998;744-750.
107. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
108. Naslund J., Thyberg J., Tjernberg L.O., Wernstedt C., Karlstrom A.R., Bogdanovic N., Gandy S.E., Lannfelt L., Terenius L., Nordstedt C. Characterization of stable complexes involving apolipoprotein E and the amyloid β-peptide in Alzheimer's disease brain. Neuron. 15:1995;219-228.
109. O'Hara R., Yesavage J.A., Kraemer H.C., Mauricio M., Friedman L.F., Murphy G.M.J. The apoE-ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J. Am. Geriatr. Soc. 46:1998;1493-1498.
110. Ohm T.G., Scharnagl H., Marz W., Bohl J. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol. (Berlin). 98:1999;273-280.
111. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
112. Payami H., Grimslid H., Oken B., Camicioli R., Sexton G., Dame A., Howieson D., Kaye J. A prospective study of cognitive health in the elderly (Oregon brain aging study): effects of family history and apolipoprotein E genotype. Am. J. Hum. Genet. 60:1997;948-956.
113. Pedersen W.A., Chan S.L., Mattson M.P. A mechanism for the neuroprotective effect of lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74:2000;1426-1433.
114. Perls T.T. Centenarians prove the compression of morbidity hypothesis, but what about the rest of us who are genetically less fortunate? Med. Hypotheses. 49:1997;405-407.
115. Perls T.T., Bubrick E., Wager C.G., Vijg J., Kruglyak L. Siblings of centenarians live longer. Lancet. 351:1998;1560.
116. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58:2001;1985-1992.
117. Pickle, L.W., Mungiole, M., Jones, G.K., White, A.A., 1996. Atlas of United States Mortality. National Center for Health Statiistics, Hyatsville, MD.
118. Pirttila T., Soininen H., Mehta P.D., Heinonen O., Lehtimaki T., Bogdanovic N., Paljarvi L., Kim K.S., Kosunen O., Winblad B., Riekkinen P.S., Wisniewski H.M. Apolipoprotein E genotype and amyloid load in Alzheimer's disease and control brains. Neurobiol. Aging. 18:1997;121-127.
119. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
120. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinisto L., Halonen P., Kontula K. Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. New Engl. J. Med. 333:1995;1242-1247.
121. Pratico D., Rokach J., Tangirala R.K. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J. Neurochem. 73:1999;736-741.
122. Puca A.A., Daly M.J., Brewster S.J., Matise T.C., Barrett J., Shea-Drinkwater M., Kang S., Joyce E., Nicoli J., Benson E., Kunkel L.M., Perls T. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10505-10508.
123. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med. 27:1999;544-553.
124. Rea I.M., Mc D.I., McMaster D., Smye M., Stout R., Evans A. Apolipoprotein E alleles in nonagenarian subjects in the Belfast elderly longitudinal free-living ageing study (BELFAST). Mech. Ageing Dev. 122:2001;1367-1372.
125. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., Hyman B.T. Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 44:1994;1513-1516.
126. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7:2000;321-331.
127. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., Duff K.E. A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8:2001;890-899.
128. Reilly S.L., Ferrell R.E., Sing C.F. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. Part III. Correlations and covariances. Am. J. Hum. Genet. 55:1994;1001-1018.
129. Riley K.P., Snowdon D.A., Saunders A.M., Roses A.D., Mortimer J.A., Nanayakkara N. Cognitive function and apolipoprotein E in very old adults: findings from the nun study. J. Gerontol. B Psychol. Sci. Soc. Sci. 55:2000;69-75.
130. Rubinsztein D.C., Easton D.F. Apolipoprotein E genetic variation and Alzheimer's disease: a meta-analysis. Dement. Geriatr. Cogn. Disord. 10:1999;199-209.
131. Sabo T., Lomnitski L., Nyska A., Beni S., Maronpot R.R., Shohami E., Roses A.D., Michaelson D.M. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience. 101:2000;879-884.
132. Sanan D.A., Weisgraber K.H., Russell S.J., Mahley R.W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A.D., Strittmatter W.J. The apoE associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94:1994;860-869.
133. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
134. Schachter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the apoE and ACE loci. Nat. Genet. 6:1994;29-32.
135. Schiefermeier M., Kollegger H., Madl C., Schwarz C., Holzer M., Kofler J., Sterz F. Apolipoprotein E polymorphism: survival and neurological outcome after cardiopulmonary resuscitation. Stroke. 31:2000;2068-2073.
136. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9649-9653.
137. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., Kostner G.M. Apolipoprotein E-ε4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin. Genet. 50:1996;293-299.
138. Scott B.L., Welch K., deSerrano V., Moss N.C., Roses A.D., Strittmatter W.J. Human apolipoprotein E accelerates microtubule polymerization in vitro. Neurosci. Lett. 245:1998;105-108.
139. Shih S.J., Allan C., Grehan S., Tse E., Moran C., Taylor J.M. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem. 275:2000;31567-31572.
140. Shimokata H., Yamada Y., Nakagawa M., Okubo R., Saido T., Funakoshi A., Miyasaka K., Ohta S., Tsujimoto G., Tanaka M., Ando F., Niino N. Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences' longitudinal study of aging (NILS-LSA). J. Epidemiol. 10:2000;S46-S55.
141. Slooter A.J., Cruts M., Ott A., Bots M.L., Witteman J.C., Hofman A., Van B.C., Breteler M.M., van D.M. The effect of APOE on dementia is not through atherosclerosis: the Rotterdam study. Neurology. 53:1999a;1593-1595.
142. Slooter A.J., Houwing-Duistermaat J.J., van H.F., Cruts M., Van B.C., Breteler M.M., Hofman A., Stijnen T., van D.M. Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam study. J. Neurol. 246:1999b;304-308.
143. Small B.J., Basun H., Backman L. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. Psychol. Aging. 13:1998;80-87.
144. Small B.J., Graves A.B., McEvoy C.L., Crawford F.C., Mullan M., Mortimer J.A. Is apoE-ε4 a risk factor for cognitive impairment in normal aging? Neurology. 54:2000;2082-2088.
145. Smit M., de K.P., Rosseneu M., Bury J., Klasen E., Frants R., Havekes L. Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum. Genet. 80:1988;287-292.
146. Smith J.D. Apolipoprotein E4: an allele associated with many diseases. Ann. Med. 32:2000;118-127.
147. Smith G.E., Bohac D.L., Waring S.C., Kokmen E., Tangalos E.G., Ivnik R.J., Petersen R.C. Apolipoprotein E genotype influences cognitive phenotype in patients with Alzheimer's disease but not in healthy control subjects. Neurology. 50:1998a;355-362.
148. Smith J.D., Sikes J., Levin J.A. Human apolipoprotein E allele-specific brain expressing transgenic mice. Neurobiol. Aging. 19:1998b;407-413.
149. Staehelin H.B., Perrig-Chiello P., Mitrache C., Miserez A.R., Perrig W.J. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol. Scand. 100:1999;53-60.
150. Stengard J.H., Zerba K.E., Pekkanen J., Ehnholm C., Nissinen A., Sing C.F. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 91:1995;265-269.
151. Stengard J.H., Weiss K.M., Sing C.F. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum. Genet. 103:1998;234-241.
152. Stewart R., Russ C., Richards M., Brayne C., Lovestone S., Mann A. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African-Caribbean population. Dement. Geriatr. Cogn. Disord. 12:2001;251-256.
153. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericak-Vance M.A., Schmechel D., Roses A.D. Isoform-specific interactions of apoE with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11183-11186.
154. Tammi A., Ronnemaa T., Rask-Nissila L., Miettinen T.A., Gylling H., Valsta L., Viikari J., Valimaki I., Simell O. Apolipoprotein E phenotype regulates cholesterol absorption in healthy 13-month-old children - the STRIP study. Pediatr. Res. 50:2001;688-691.
155. Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B., Mayeux R. The apoE-ε4 allele and the risk of Alzheimer's disease among African-Americans, whites and Hispanics. JAMA. 279:1998;751-755.
156. Tang M.X., Cross P., Andrews H., Jacobs D.M., Small S., Bell K., Merchant C., Lantigua R., Costa R., Stern Y., Mayeux R. Incidence of AD in African-Americans, Caribbean Hispanics and Caucasians in northern Manhattan. Neurology. 56:2001;49-56.
157. Tardiff B.E., Newman M.F., Saunders A.M., Strittmatter W.J., Blumenthal J.A., White W.D., Croughwell N.D., Davis R.J., Roses A.D., Reves J.G. Preliminary report of a genetic basis for cognitive decline after cardiac operations: the neurologic outcome research group of the Duke heart center. Ann. Thorac. Surg. 64:1997;715-720.
158. Tesseur I., Van Dorpe J., Spittaels K., Van den H.C., Moechars D., Van Leuven F. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156:2000;951-964.
159. Teter B., Xu P.T., Gilbert J.R., Roses A.D., Galasko D., Cole G.M. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J. Neurochem. 73:1999;2613-2616.
160. Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., Zlokovic B., Smith J.D., LaDu M.J., Rostagno A., Frangione B., Ghiso J. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β-peptides. Biochem. J. 348(2):2000;359-365.
161. Traykov L., Rigaud A.S., Caputo L., Couderc R., Coste J., Michot J.L., de Rotrou J., Amouyel P., Forette F., Boller F. Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease. Eur. J. Neurol. 6:1999;415-421.
162. Turic D., Fisher P.J., Plomin R., Owen M.J. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neurosci. Lett. 299:2001;97-100.
163. Utermann G., Langenbeck U., Beisiegel U., Weber W. Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet. 32:1980;339-347.
164. Vincent B., Smith J.D. Astrocytes down-regulate neuronal β-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner. Eur. J. Neurosci. 14:2001;256-266.
165. von Muhlen D.G., Barrett-Connor E., Schneider D.L., Morin P.A., Parry P. Osteoporosis and apolipoprotein E genotype in older adults: the Rancho Bernardo study. Osteoporos. Int. 12:2001;332-335.
166. Warzok R.W., Kessler C., Apel G., Schwarz A., Egensperger R., Schreiber D., Herbst E.W., Wolf E., Walther R., Walker L.C. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis. Assoc. Disord. 12:1998;33-39.
167. Wilson P.W., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 16:1996;1250-1255.
168. Wisniewski T., Castano E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1994;1030-1035.
169. Xhignesse M., Lussier-Cacan S., Sing C.F., Kessling A.M., Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler. Thromb. 11:1991;1100-1110.
170. Yamaguchi H., Sugihara S., Ogawa A., Oshima N., Ihara Y. Alzheimer β-amyloid deposition enhanced by apoE-ε4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J. Neuropathol. Exp. Neurol. 60:2001;731-739.
171. Yang D.S., Small D.H., Seydel U., Smith J.D., Hallmayer J., Gandy S.E., Martins R.N. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience. 90:1999;1217-1226.
172. Yu Y.W., Lin C.H., Chen S.P., Hong C.J., Tsai S.J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E-ε4 and non-ε4 carriers. Neurosci. Lett. 294:2000;179-181.
173. Zekraoui L., Lagarde J.P., Raisonnier A., Gerard N., Aouizerate A., Lucotte G. High frequency of the apolipoprotein E4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum. Biol. 69:1997;575-581.